Beyondspring inc.

Major-Pharmaceuticals

BYSI


28 Liberty Street
New York , NY 10005

Executive/
Director

Price

  • Last Close
  • $ 1.69
    $ +0.1 6.29 %
    Jan 3, 2025
  • 52-Week High/Low
  • $3.63 - $0.69
  • YTD
  • 7%

  • Trading Volume
  • 98
  • Market Cap Full
  • $ 65.9M
  • Shares Outstanding
  • 39M
    Dec 31, 2022
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Q1 - - -11.9% -14.6% -5% -11.5% -51.4% -40.4% 305.4% 7%
Q2 - 115.2% -0.5% 37.7% 4% -5.7% -34.6% 5.4% -30.4% -
Q3 - -14% -3.8% -27.6% 8% 53.2% -31.3% -32.2% 0.5% -
Q4 - -23.5% -28.1% -9.4% -8.3% -71.7% 89.9% 16.7% -19.8% -
J F M A M J J A S O N D
2025 7% - - - - - - - - - - -
2024 10.4% 39.8% 162.8% -47.8% 39.9% -4.9% -22.4% 0.5% - - - -18.1%
    2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
    0%0%0%-36%-17%-20%-64%-58%-53%78%7%

Earnings

2016 2017 2018 2019 2020 2021 2022 2023
Q1 - 2.66 -0.61 -0.32 -0.58 -0.44 - -
Q2 - 0.39 -0.54 -0.32 -0.46 -0.49 - -
Q3 - 0.68 -0.65 -0.37 -0.48 -0.47 - -
Q4 - 0.68 - -0.54 -0.51 -0.24 - -
A 0 4.4 -1.8 -1.6 -2 -1.6 0 0

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2018 2019 2020 2021 2022
Mar 22.5 - - - -
Jun - - - - -
Sep - - - - -
Dec 23.2 27.9 39.1 38.9 39

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover - - - - -
Fixed Asset Turnover 0.5 0.3 - - -
Total Asset Turnover - - - - -
Leverage
Debt Ratio - - - - -
Debt – Equity Ratio - - - - -
Interest Coverage 9.3 33 21.3 20 19.3
Equity multiplier -0.1 0.2 - - -0.1